A friend mentions she's on "bioidentical hormones" from a compounding pharmacy. Another is on Estrace and a progesterone capsule prescribed by her OB-GYN. Both believe the other one is taking something riskier. Neither is right.

The confusion is understandable. The marketing around bioidentical hormones has been extraordinarily effective at creating the impression of a meaningful distinction that the science does not support.

0 Clinical trials showing compounded bioidentical hormones are safer or more effective than FDA-approved HRT — NAMS position statement, 2022
$300/mo Average cost of compounded bioidentical hormone protocols from specialty clinics: versus $30–80/month for FDA-approved equivalent products
±35% Dose variation found in compounded hormone preparations in FDA audit testing — FDA-approved products must stay within ±10%

What "bioidentical" actually means

A hormone is bioidentical if its molecular structure is identical to the hormone naturally produced by the human body. Estradiol is estradiol: the molecule is the same whether it comes from a compounding pharmacy or from an FDA-approved patch, gel, or pill. Progesterone (not progestogen: the synthetic version) is similarly bioidentical in both compounded creams and in Prometrium, an FDA-approved oral micronized progesterone.

This is the part the marketing conveniently glosses over: many FDA-approved HRT products already are bioidentical. The distinction isn't "bioidentical versus not bioidentical." It's "regulated versus unregulated production."

Research Note

The FDA issued warning letters to compounding pharmacies specifically for making unsupported safety claims about their bioidentical hormone products: claiming reduced cancer risk, improved safety profiles, or more "natural" effects without clinical evidence. NAMS's 2022 position statement explicitly states: "There is no evidence that compounded bioidentical hormones are safer or more effective than government-approved menopausal hormone therapy products." The Endocrine Society and ACOG have issued identical positions.

Where compounding has legitimate uses

This isn't an argument against all compounding. Compounding fills real gaps. Women who need a dose unavailable in standard products, a delivery method not commercially produced (such as a specific cream concentration for vaginal atrophy), or who have allergies to ingredients in standard formulations may genuinely benefit from a compounding pharmacy.

The problem is that the majority of women choosing compounded bioidenticals aren't doing so for these legitimate reasons. They're choosing them because of marketing that positioned them as safer or more "in tune" with the body — a claim not supported by evidence. They're often paying significantly more for a product with less regulatory oversight.

Worth Knowing

Compounded hormone products are not tested by the FDA for safety or efficacy before sale. Dose consistency in compounded preparations has been found to vary significantly in independent testing: meaning the dose you receive may not match what was prescribed. This is a real concern for hormones where the effective and excessive doses can be close together, particularly with testosterone compounding in women.

The BHRT clinic model

Many women accessing compounded bioidenticals aren't doing so through their OB-GYN. They're visiting specialist BHRT clinics or functional medicine practitioners who run extensive hormone panels, prescribe customized compounded protocols, and charge premium fees for the service. Some of these practitioners offer genuinely valuable care. Others are practicing in ways that leading menopause societies describe as evidence-free.

Salivary hormone testing: widely used in BHRT clinic protocols: is not validated for monitoring HRT dosing. Blood levels, particularly estradiol and progesterone, remain the standard. If your provider is adjusting your hormones based exclusively on salivary panels, this is worth questioning directly.

Questions worth asking your provider

→

"What is the specific reason you're recommending compounded rather than FDA-approved HRT for my situation?"

→

"Is there an FDA-approved product that could achieve the same outcome? If not, why not?"

→

"How will you monitor my hormone levels during treatment, and how often?"

→

If a provider specifically claims their compounded hormones are safer than conventional HRT and can't provide trial evidence, that is a red flag worth taking seriously.

⚕

The February 2026 FDA removal of the HRT black box warning updated risk information based on the full body of evidence from the WHI reanalysis and subsequent studies. FDA-approved HRT, when started within 10 years of menopause onset in women without contraindications, has a favorable benefit-risk profile. If you've been avoiding conventional HRT due to safety concerns, this is a good moment to revisit that conversation with a menopause-specialist OB-GYN using current guidance.

Medical Disclaimer: This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

  1. NAMS Position Statement. Bioidentical hormone therapy. Menopause. 2022;29(5):499–502.
  2. Endocrine Society Position Statement. Bioidentical hormones. 2020. https://www.endocrine.org
  3. Pinkerton JV, et al. ACOG Practice Bulletin on hormone therapy in primary ovarian insufficiency and menopause. Obstet Gynecol. 2022;139(6):1072–1088.
  4. de Villiers TJ, et al. International Menopause Society revised global consensus statement on menopausal hormone therapy. Climacteric. 2016;19(4):313–315.
  5. FDA. Bioidentical hormones — questions and answers. FDA Consumer Updates 2023.